APOC3 and Hepatic steatosis: When comparing patients with TT versus CT/CC genotypes of ApoC-III rs2854116/FokI, no significant differences (p > 0.05) were found in the presence of hepatic steatosis, liver cirrhosis, dyslipidemia, hypertriglyceridemia, hypercholesterolemia, diabetes status, or diabetes complications (nephropathy, retinopathy, neuropathy).